InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,408.42
(
-1.73%
)
US TECH 100
17,870.94
(
-3.09%
)
Dow Jones
40,345.41
(
-1.01%
)
Brent Oil
70.89
(
0.00%
)
Bitcoin
53,816.27
(
-0.66%
)
Post# of 253060
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 838
Posts 120392
Boards Moderated 18
Alias Born 09/05/2002

DewDiligence

Member Level

Re: zipjet post# 104628

Monday, 09/20/2010 2:57:56 PM

Monday, September 20, 2010 2:57:56 PM

Post# of 253060

…claiming that they will convert the entire Copaxone market to the 0.5ml by EOY 2011.

Total BS, IMHO.

What is it about Copaxone in a more concentrated form (0.5ml vs 1.0ml) that is patentable?

Any patents that issue on this product probably won’t stand up to scrutiny; however, Teva may be able to get three years of Hatch-Waxman marketing exclusivity for a new formulation.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up